Bioorganic and Medicinal Chemistry p. 3768 - 3779 (2017)
Update date:2022-07-29
Topics: Structure-Activity Relationship (SAR) Studies Clinical Trials High-Throughput Screening Mechanism of Action Rational Drug Design In Vitro and In Vivo Studies Role of SCD1 in Cancer Challenges and Future Directions
Imamura, Keisuke
Tomita, Naoki
Kawakita, Youichi
Ito, Yoshiteru
Ono, Kouji
Nii, Noriyuki
Miyazaki, Tohru
Yonemori, Kazuko
Tawada, Michiko
Sumi, Hiroyuki
Satoh, Yoshihiko
Yamamoto, Yukiko
Miyahisa, Ikuo
Sasaki, Masako
Satomi, Yoshinori
Hirayama, Megumi
Nishigaki, Ryuichi
Maezaki, Hironobu
A lead compound A was identified previously as an stearoyl coenzyme A desaturase (SCD) inhibitor during research on potential treatments for obesity. This compound showed high SCD1 binding affinity, but a poor pharmacokinetic (PK) profile and limited chem
View MoreNantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Contact:0091-265-2313036
Address:311, ATLANTIS HEIGHTS SARABHAI MAIN ROAD,VADIWADI ,VADODARA
Shanghai Mintchem Development ., Ltd
Contact:0086 21 5190 8570
Address:R602,4#,89Nong, Mudan Road Pudong Shanghai China
Jiangsu Hualin Chemical Co.,Ltd
Contact:86-25-87787395
Address:jiangsu china
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Doi:10.1021/ja00353a020
(1983)Doi:10.1002/hlca.19620450609
(1962)Doi:10.1016/S0960-894X(03)00483-9
(2003)Doi:10.1016/j.bmc.2008.06.045
(2008)Doi:10.1016/j.carres.2008.06.016
(2008)Doi:10.1021/ja01205a521
()